News - MedTech & Diagnostics
Robotic-assisted gynae surgery gains ground: Does it deliver beyond the hype?

A Sydney hospital continues to break new ground, becoming one of the first public hospitals in Australia to offer robotic-assisted gynaecological surgery – further cementing its reputation as a surgical innovator. The Nepean Hospital was also the first public facility in New South Wales to introduce the da Vinci robotic system, setting a precedent in the state’s public health sector.
“In the public sector, it’s a very new thing to perform gynaecological surgery robotically. We’re only the second or third hospital in Australia doing it,” said Dr Naman Dahiya, Gynaecologist at Nepean Hospital.
“Complex surgeries [including hysterectomies or treating endometriosis] often involve bowel resections or urology procedures at the same time, and the benefits of robotic surgery are significantly greater than traditional laparoscopic surgery – for both the surgeon and the patient.”
The ergonomic advantages of robotic surgery are also noteworthy. Surgeons benefit from a seated operating position, reduced fatigue, and enhanced precision – all of which contribute to long-term surgical sustainability.
“The ports don’t move as much, so patients get less pain at the incisions,” Dr Dahiya explained. “We can also operate at lower gas pressures inside the abdomen, which means less pain afterwards. We’ve noticed that patients having big surgeries, including bowel resections, often go home the next day. For some hysterectomies, they’re even going home the same day.”
As uptake increases in gynaecology, the broader value of robot-assisted laparoscopic surgery compared to conventional laparoscopy remains a point of clinical discussion.
Among all surgical disciplines, robotic technology demonstrates the clearest advantage in radical prostatectomy for prostate cancer. Compared to conventional laparoscopy, robotic-assisted prostatectomy is associated with reduced intraoperative blood loss and superior outcomes in postoperative sexual function and urinary continence.
However, a recent review suggests the benefits of robotic-assisted surgery in gynaecology are less conclusive. Evidence regarding quality of life, functional outcomes, and cost-effectiveness remains mixed, with studies producing inconsistent findings and no clear consensus.
Dr Caroline Ruth Mathias, a final-year RANZCOG fellow who completed her surgical training at Nepean Hospital, stated “If robotic surgery isn’t already the present, it’s definitely the future – and Nepean has really led the way in bringing it into the public sector.”
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News - MedTech & Diagnostics

Aussie medtech NeedleCalm sharpens its edge with new Co-Founder
After nearly a decade of grit and solo determination, Lauren Barber, Founder of Aussie medtech startup NeedleCalm, is no longer […]
MoreNews - Pharmaceuticals

Australia’s immunisation strategy faces its toughest test yet
In an ecosystem still adjusting to the aftershocks of the COVID-19 pandemic, the future of vaccination in Australia is under […]
MoreNews - Pharmaceuticals

World-first count redefines role of IVF
A world-first estimate shows assisted reproductive technology (ART) is now part of everyday life for millions of families across the […]
MoreNews - Pharmaceuticals

Rethinking Australia’s hepatitis strategy: World Hepatitis Day
Coinciding with World Hepatitis Day, a new analysis by Hepatitis Australia reveals the face of hepatitis in Australia is changing […]
More